Holen Sie sich die Stockscreener-App
21.05
2.02%
-0.69
Schlusskurs vom Vortag:
$21.74
Offen:
$21.66
24-Stunden-Volumen:
556.51K
Relative Volume:
0.43
Marktkapitalisierung:
$2.10B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-804.34M
KGV:
-2.237
EPS:
-9.41
Netto-Cashflow:
$-531.06M
1W Leistung:
+0.71%
1M Leistung:
-22.97%
6M Leistung:
-58.19%
1J Leistung:
-46.52%
1-Tages-Spanne:
$20.68
$21.84
1-Wochen-Bereich:
$17.42
$23.43
52-Wochen-Spanne:
$15.79
$55.70
Biohaven Ltd Stock (BHVN) Company Profile
Firmenname
Biohaven Ltd
Sektor
Branche
Telefon
203-404-0410
Adresse
215 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie BHVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
21.14 | 2.10B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.80 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.74 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
628.63 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
258.66 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
248.64 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-09-16 | Eingeleitet | Jefferies | Buy |
| 2024-09-04 | Eingeleitet | Bernstein | Outperform |
| 2024-07-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2023-12-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-01-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-04 | Eingeleitet | JP Morgan | Overweight |
| 2022-12-02 | Eingeleitet | BTIG Research | Buy |
| 2022-10-26 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-08-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-05-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Herabstufung | UBS | Buy → Neutral |
| 2021-08-03 | Bestätigt | Canaccord Genuity | Buy |
| 2021-03-11 | Eingeleitet | UBS | Buy |
| 2020-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-17 | Eingeleitet | Cowen | Outperform |
| 2020-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2019-11-22 | Eingeleitet | Wedbush | Outperform |
| 2019-06-25 | Bestätigt | Canaccord Genuity | Buy |
| 2019-05-06 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Bestätigt | Needham | Buy |
| 2018-07-03 | Bestätigt | Needham | Buy |
| 2018-07-02 | Bestätigt | Needham | Buy |
| 2018-04-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Bestätigt | Canaccord Genuity | Buy |
| 2017-12-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-03 | Bestätigt | Needham | Buy |
Alle ansehen
Biohaven Ltd Aktie (BHVN) Neueste Nachrichten
Biohaven secures $600m financing as it awaits FDA prodrug decision - Yahoo
Biohaven (NYSE:BHVN) Given New $57.00 Price Target at Robert W. Baird - Defense World
BHVN’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
Why BioHaven Stock Is Soaring Today - Mitrade
A Guide To The Risks Of Investing In Biohaven Ltd (BHVN) - knoxdaily.com
Biohaven Ltd. Receives Buy Rating Amid Strategic EU Resubmission and Positive FDA Outlook - TipRanks
Biohaven secures up to $600 million from Oberland Capital - Investing.com
Biohaven Rallies On Heels Of $600M Funding Agreement With OberlandBiohaven (NYSE:BHVN) - Benzinga
Biohaven announces investment of up to $600M - Hartford Business Journal
Financial Analysis: Biohaven Ltd (BHVN)’s Ratios Unveil Key Insights - DWinneX
Biohaven (BHVN) Secures Up to $600M Investment from Oberland Cap - GuruFocus
Biohaven Announces Investment by Oberland Capital - Contract Pharma
Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Biohaven Ltd. Secures $600M Investment from Oberland Capital - TipRanks
Biohaven Announces Investment Up To $600 Mln By Oberland Capital - marketscreener.com
Why Biohaven Ltd. Shares Are Tumbling - TipRanks
Biohaven Lands Major $600 Million Deal With Oberland Capital - Finimize
Biohaven Signs Deal for Investment of up to $600 Million by Oberland; Shares up Pre-Bell - marketscreener.com
Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider
Biohaven Announces Investment up to $600 Million by Oberland Capital - PR Newswire
Biohaven (NYSE:BHVN) Upgraded at William Blair - Defense World
Biohaven (BHVN) Faces Market Setback After EMA Withdrawal - GuruFocus
Wells Fargo & Company MN Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven share price undervaluing pipeline potential, says RBC Capital - Yahoo Finance
Why Biohaven Stock Plummeted by More Than 15% Today - Yahoo Finance
Biohaven stock slides on withdrawal of European marketing application - BioPharma Dive
Biohaven (BHVN) Withdraws EMA Application, U.S. Approval Crucial - GuruFocus
Biohaven (BHVN) Withdraws Troriluzole Application in Europe, Foc - GuruFocus
Biohaven (BHVN) Stock Drops After Withdrawal of EU Drug Applicat - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Biohaven Ltd. Stock Faces Turbulence Amid Strategic Shifts - TipRanks
Biohaven Ltd (NYSE:BHVN) Shares Surged 25.27% In A Week – But Will They Keep Going Up? - Marketing Sentinel
Biohaven Pharma stock tumbles after withdrawal of Dazluma application in EU - Investing.com UK
BHVN’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com
Biohaven Ltd (BHVN) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Biohaven Ltd [BHVN] Director makes an insider purchase of 32,700 shares worth 1.0 million. - knoxdaily.com
Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21 - Insider Monkey
Is Biohaven Ltd. (BHVN) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Insider Monkey
Stock Traders Buy Large Volume of Biohaven Call Options (NYSE:BHVN) - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd.BHVN - PR Newswire
Biohaven Ltd (BHVN)’s stock rises to 20.55 per share - uspostnews.com
Biohaven Ltd (NYSE: BHVN) Shocks Wall Street This Week With A 0.88% Stock Price Incline - Marketing Sentinel
Biohaven Pharmaceutical : Announces Pricing Of $250 Million Public Offering Of Common Shares - marketscreener.com
LPL Financial LLC Raises Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World
Q1 Earnings Estimate for Biohaven Issued By Leerink Partnrs - Defense World
BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm - Finansavisen
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Alliancebernstein L.P. - Defense World
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Franklin Resources Inc. - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - GlobeNewswire Inc.
Contrasting Biohaven (NYSE:BHVN) & Ampio Pharmaceuticals (NYSE:AMPE) - Defense World
Royalty Pharma expands board with Biohaven CEO appointment By Investing.com - Investing.com South Africa
Finanzdaten der Biohaven Ltd-Aktie (BHVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.36%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):